Home > Insider Trading > Filing (0000950142-15-001511)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1461993	Cempra Inc.	CEMP	Pharmaceutical Preparations (2834)	262644445

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1120478	Md A Dov Goldstein	888 7Th Avenue 12Th Floor New York NY 10106		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2015-06-22	5,000	$0.00	5,050	No	4	M	Direct
Common Stock	Acquisiton	2015-06-22	15,000	$0.00	20,050	No	4	M	Direct
Common Stock	Acquisiton	2015-06-22	15,000	$0.00	35,050	No	4	M	Direct
Common Stock	Acquisiton	2015-06-22	15,000	$0.00	50,050	No	4	M	Direct
Common Stock	Disposition	2015-06-22	50,000	$35.74	50	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option	Disposition	2015-06-22	5,000	$0.00	5,000	$23.51
Common Stock	Stock Option	Disposition	2015-06-22	15,000	$0.00	15,000	$13.10
Common Stock	Stock Option	Disposition	2015-06-22	15,000	$0.00	15,000	$6.79
Common Stock	Stock Option	Disposition	2015-06-22	15,000	$0.00	15,000	$7.62

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
10,000		2024-12-31	No	4	M	Direct
0	2015-01-01	2024-01-07	No	4	M	Direct
0	2014-01-01	2023-02-03	No	4	M	Direct
0	2013-01-01	2022-03-20	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	2,193,110	Indirect	By Aisling Capital II, LP

Footnotes

Sold pursuant to 10b5-1 Plan.
The reportable securities are owned directly by Aisling Capital II, LP ("Aisling"), and held indirectly by Aisling Capital Partners, LP ("Aisling GP"), as general partner of Aisling, and Aisling Capital Partners, LLC, as general partner of Aisling GP. Dr. Goldstein is a member of the investment committee of Aisling. Dr. Goldstein disclaims beneficial ownership of these securities and this report is not an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interest therein.
Exercised pursuant to 10b5-1 Plan.
The option vests on the following schedule: 1/12th of the shares vest monthly at the end of each month over 12 months, beginning January 1, 2015.
These stock options are held by Dr. Goldstein for the benefit of Aisling Capital LLC. Dr. Goldstein disclaims beneficial ownership of these securities and this report is not an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interest therein.